HIMS directional thesis
The public GLP-1 telehealth name slides as the compounded-semaglutide cash cow gets cut off by regulators, leaving guidance built on extrapolated run-rate numbers exposed.
“it's only twice as many people as the original challenge.”8:20claim_id
mcl_5e917c85aa18097806open evidence ↗Human-reviewed public claim.
Evidence URL, source timestamp, and excerpt are attached to this permanent claim page.
Creators or reviewers can request reclassification, context, or entity corrections without erasing the source record.